Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer.
about
Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumoursGranulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancerLaevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology GroupThe use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerp53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancerContinuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneouslyPhase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: a report of two cases.Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.
P2860
Q24186714-A8F9BE39-5C95-460A-B96E-C2487734A00AQ28378467-FF6C0181-7DA1-4362-87B1-8F047211B097Q33488519-AE073E61-B89C-4EBF-A08D-F58881048CEDQ36080547-0BFC827A-DB30-4CA4-9CF8-29176709B9ADQ36135594-0D6D70B4-8178-4231-9A2F-D5AB673F4938Q36140972-7D840E92-ECCF-4D41-BB09-A8574A88384FQ36140983-ADDF7777-0824-4A52-BF61-F18CBC2F9410Q36291690-EDF31ACA-0029-44B3-A107-31C357E971E0Q40603519-D515E7B3-DA29-4DD8-99CC-2FEA0319D27FQ47409875-B47E01EF-E318-4D67-A816-4A80567D1832
P2860
Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer.
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Effects of recombinant human g ...... s with advanced breast cancer.
@ast
Effects of recombinant human g ...... s with advanced breast cancer.
@en
type
label
Effects of recombinant human g ...... s with advanced breast cancer.
@ast
Effects of recombinant human g ...... s with advanced breast cancer.
@en
prefLabel
Effects of recombinant human g ...... s with advanced breast cancer.
@ast
Effects of recombinant human g ...... s with advanced breast cancer.
@en
P2093
P356
P1476
Effects of recombinant human g ...... s with advanced breast cancer.
@en
P2093
Vermorken JB
Wagstaff J
van Groeningen CJ
P304
P356
10.1093/JNCI/83.21.1546
P407
P577
1991-11-01T00:00:00Z